Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivoJohn A. Zuris, David R. Liu, David B. Thompson et al.|Nature Biotechnology|2014Cited by 1.5k
A highly efficient transgene knock-in technology in clinically relevant cell typesAlexander G. Allen, John A. Zuris, Samia Khan et al.|Nature Biotechnology|2023Cited by 66
NADPH Inhibits [2Fe-2S] Cluster Protein Transfer from Diabetes Drug Target MitoNEET to an Apo-acceptor ProteinJohn A. Zuris, Patricia A. Jennings, Rachel Nechushtai et al.|Journal of Biological Chemistry|2012Cited by 40
Comparative Studies Reveal Robust HbF Induction By Editing of HBG1/2 Promoters or BCL11A Erythroid-Enhancer in Human CD34+ Cells but That BCL11A Erythroid-Enhancer Editing Is Associated with Selective Reduction in Erythroid Lineage Reconstitution in a Xenotransplantation ModelKai‐Hsin Chang, Haiyan Jiang, Minerva E. Sanchez et al.|Blood|2018Cited by 9
PS1518 GENOME EDITING OF HBG1/2 PROMOTER LEADS TO ROBUST HBF INDUCTION IN VIVO, WHILE EDITING OF BCL11A ERYTHROID ENHANCER RESULTS IN ERYTHROID DEFECTSJonathon Heath, Kaiwen Chang, Edouard De Dreuzy et al.|HemaSphere|2019Cited by 8